Literature DB >> 19931568

Noradrenergic modulation of extinction learning and exposure therapy.

Devin Mueller1, Shawn P Cahill.   

Abstract

Memory consolidation is enhanced by emotional arousal, an effect mediated by noradrenergic beta-receptor signaling. Norepinephrine strengthens consolidation of both appetitive and aversive learning, and is implicated in extinction of conditioned responses. In this review, we summarize work on the noradrenergic mechanisms of extinction learning and implications for extinction-based exposure therapy. The evidence suggests that norepinephrine release evoked by conditioned stimuli during extinction strengthens extinction memory via beta-receptor signaling. The modulatory effect of norepinephrine during extinction depends on predictable presentation of conditioned stimuli and optimal levels of norepinephrine release. Mechanistically, norepinephrine acts to increase cellular excitability and enhance synaptic plasticity within extinction-related neural circuitry. Currently, drugs that modulate norepinephrine are being used to treat symptoms of anxiety disorders, and are now being tested as pharmacotherapeutic prophalactics in the prevention of chronic posttraumatic stress reactions and as adjuncts to extinction-based exposure therapy. Studies of these new applications of noradrenergic drugs show a converging pattern of results with basic science suggesting ways in which basic laboratory findings can be translated into procedures to enhance clinical outcomes. Copyright 2009 Elsevier B.V. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19931568     DOI: 10.1016/j.bbr.2009.11.025

Source DB:  PubMed          Journal:  Behav Brain Res        ISSN: 0166-4328            Impact factor:   3.332


  54 in total

1.  Compound stimulus presentation and the norepinephrine reuptake inhibitor atomoxetine enhance long-term extinction of cocaine-seeking behavior.

Authors:  Patricia H Janak; M Scott Bowers; Laura H Corbit
Journal:  Neuropsychopharmacology       Date:  2011-11-16       Impact factor: 7.853

2.  Norepinephrine in prelimbic cortex delays extinction of amphetamine-induced conditioned place preference.

Authors:  Emanuele Claudio Latagliata; Pamela Saccoccio; Chiara Milia; Stefano Puglisi-Allegra
Journal:  Psychopharmacology (Berl)       Date:  2015-12-12       Impact factor: 4.530

3.  Post-retrieval propranolol treatment does not modulate reconsolidation or extinction of ethanol-induced conditioned place preference.

Authors:  Laura Font; Christopher L Cunningham
Journal:  Pharmacol Biochem Behav       Date:  2012-01-21       Impact factor: 3.533

4.  Does prior traumatization affect the treatment outcome of CBT for panic disorder? The potential role of the MAOA gene and depression symptoms.

Authors:  Sebastian Trautmann; Jan Richter; Markus Muehlhan; Michael Höfler; Hans-Ulrich Wittchen; Katharina Domschke; Andreas Ströhle; Alfons O Hamm; Heike Weber; Tilo Kircher; Volker Arolt; Alexander L Gerlach; Georg W Alpers; Thomas Fydrich; Thomas Lang; Andreas Reif
Journal:  Eur Arch Psychiatry Clin Neurosci       Date:  2017-07-15       Impact factor: 5.270

5.  Inhibition of β-adrenergic receptors induces a persistent deficit in retrieval of a cocaine-associated memory providing protection against reinstatement.

Authors:  James M Otis; Devin Mueller
Journal:  Neuropsychopharmacology       Date:  2011-05-04       Impact factor: 7.853

Review 6.  Diminishing fear: Optogenetic approach toward understanding neural circuits of fear control.

Authors:  Natalia V Luchkina; Vadim Y Bolshakov
Journal:  Pharmacol Biochem Behav       Date:  2017-05-11       Impact factor: 3.533

7.  Neurobiological dissociation of retrieval and reconsolidation of cocaine-associated memory.

Authors:  James M Otis; Kidane B Dashew; Devin Mueller
Journal:  J Neurosci       Date:  2013-01-16       Impact factor: 6.167

8.  Delayed noradrenergic activation in the dorsal hippocampus promotes the long-term persistence of extinguished fear.

Authors:  Ning Chai; Jian-Feng Liu; Yan-Xue Xue; Chang Yang; Wei Yan; Hui-Min Wang; Yi-Xiao Luo; Hai-Shui Shi; Ji-Shi Wang; Yan-Ping Bao; Shi-Qiu Meng; Zeng-Bo Ding; Xue-Yi Wang; Lin Lu
Journal:  Neuropsychopharmacology       Date:  2014-02-19       Impact factor: 7.853

Review 9.  Drug discovery strategies that focus on the endocannabinoid signaling system in psychiatric disease.

Authors:  Ryan Wyrofsky; Paul McGonigle; Elisabeth J Van Bockstaele
Journal:  Expert Opin Drug Discov       Date:  2014-12-09       Impact factor: 6.098

10.  MAOA and mechanisms of panic disorder revisited: from bench to molecular psychotherapy.

Authors:  A Reif; J Richter; B Straube; M Höfler; U Lueken; A T Gloster; H Weber; K Domschke; L Fehm; A Ströhle; A Jansen; A Gerlach; M Pyka; I Reinhardt; C Konrad; A Wittmann; B Pfleiderer; G W Alpers; P Pauli; T Lang; V Arolt; H-U Wittchen; A Hamm; T Kircher; J Deckert
Journal:  Mol Psychiatry       Date:  2013-01-15       Impact factor: 15.992

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.